EPGL
AZN icon

Evelyn Partners Group Ltd’s AstraZeneca AZN Stock Holding History

Evelyn Partners Group Ltd’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.5B Buy
+2,237,205
New +$421M 88.6% 1

Other funds holding AZN

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Evelyn Partners Group Ltd's AZN Position: Q2 2026 in Review

Evelyn Partners Group Ltd opened a new position in AstraZeneca (AZN) in Q2 2026: 2,237,205 shares worth $41.5B. The stake represents 88.6% of the portfolio and ranks #1 among its holdings.

888 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Evelyn Partners Group Ltd held 2,237,205 shares of AstraZeneca worth $41.5B as of Q2 2026.
  • AstraZeneca was a new Evelyn Partners Group Ltd position in Q2 2026.
  • AstraZeneca made up 88.6% of Evelyn Partners Group Ltd's portfolio in Q2 2026, its #1 holding.
  • 888 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.